New Cronies are tearing retail investors up. Talk about a butt kicking. And it seems Dr. Kim is playing along nicely. Getting rid of the rif raf that he so dislikes. His hands are tied, he made a deal with the big money and that is what it is about now, money. He has opened the door to Institutional money he wants so badly and this is the cost. He will say nothing in defense of this company until the carnage is over. I don't look for any support here.
He will, he answered a very pointed email yesterday, almost right away. He says this is how biotech is. It is long term investment. We had a good year last year. They are aware of the share price. That is all folks. Nothing on partnerships or data. I asked IR for a reply from management and got it. I was looking for more but knew what the reply would be.
How often will this be repeated Johnny? How low will they take it, $5? How will we be able to negotiate decent deals with a pps falling like this and market cap dropping like a cheap date. When will the company decide to defend itself with some real data release as partnerships don't seem to be on the horizon? Try to answer some of the things that aren't so obvious as a crashing pps. Thanks.
To be negotiating from. Big pharma holds all the cards. Dr. Kim is in a terrible position here and so are we. Nothing but silence since July P2 and no updates on ongoing trials. Lots of red flags and haven't crossed the end zone once and pps down almost 50%. Where do we go from here.
I hope Dr. Kim learned something. His actions have put this company in a very difficult position.
Hope you're right cuda. Tokman's performance is my issue. Failure to execute. Failure to give promised updates. Failure to help Celluon with any kind of PR. Failure to deliver on contracts. You get the picture. And I do believe the company is facing the best year since I've been here.
Yep, don't care as long as the projected sales are big. They can issue more shares and keep management payroll going for years on projected contracts and sales. Things won't change until his salary is performance based.
You're going to be one happy fellow then as we progress toward June. Many, many ops for you.
Tells us where this phase is going or when it will end. Give us a good figure so we can make some back. Give us a timeline for news or results or partnerships, Dr. Kim doesn't seem to know. One solid year now of nothing but dilution and lost partnerships and partnerships that never came to pass. I would value some good information or data from anyone. If you can help him with this please do as I think he has tripped over his ego and it is costing this company big time. Any cheaper and we will lose the company altogether. A chump bid will get attention of a lot of players at these valuations. He needs a reality check. Next time anyone in Plymouth Meeting passes him in the hall, slap him upside the head for us and see if there is anybody at home, any reaction you get will be appreciated by a lot of folks.
last year to no credibility this year. What a turn around he engineered. Wish he could turn it the other way. Used to be able to do it with his mouth and wallet. Now he is so quiet I can almost hear him breathe, and his wallet seems to be empty.
More on P2 results? Data on 3112 not good? Ebola not working? Peer Review sucks? 1400 making people sick? Dr. Kim continuing as CEO and everything else? What did I miss. Got my buy at $7.50, put another in at $7. Really hoped it wouldn't fill, but Kim has done nothing in a year now that produced any shareholder value, and it looks like he doesn't have anything to prevent the continued decline of value.